Patents by Inventor Daniel E. Katzman

Daniel E. Katzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110306669
    Abstract: Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual.
    Type: Application
    Filed: August 22, 2011
    Publication date: December 15, 2011
    Inventors: Eyal S. Ron, Neal M. Farber, Daniel E. Katzman, Elkan R. Gamzu
  • Publication number: 20110129519
    Abstract: Methods and compositions comprising modafinil are described for treating premature ejaculation in a male individual.
    Type: Application
    Filed: February 7, 2011
    Publication date: June 2, 2011
    Inventor: Daniel E. Katzman
  • Patent number: 7943632
    Abstract: Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual apomorphine. Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual at least 1000 mg or more of L-dopa (levodopa) per day. The use of potent dopaminergic agents to stimulate emergence from an altered consciousness state, such as a coma, is disclosed.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: May 17, 2011
    Assignee: NeuroHealing Pharmaceuticals, Inc.
    Inventors: Daniel E. Katzman, Elkan R. Gamzu, Neal M. Farber, Esteban A. Fridman, Marcelo Merello
  • Patent number: 7884135
    Abstract: Methods and compositions comprising modafinil are described for treating premature ejaculation in a male individual.
    Type: Grant
    Filed: August 13, 2007
    Date of Patent: February 8, 2011
    Assignee: NeuroHealing Pharmaceuticals, Inc.
    Inventor: Daniel E. Katzman
  • Publication number: 20090318559
    Abstract: Methods and compositions comprising modafinil are described for treating premature ejaculation in a male individual.
    Type: Application
    Filed: August 13, 2007
    Publication date: December 24, 2009
    Inventor: Daniel E. Katzman
  • Publication number: 20090123545
    Abstract: Compositions are described that comprise a modafÊnil component that is a combination of the d- and l-enantiomers of modafinil and wherein the modafÊnil component is greater than 50% by weight d-modafÊnil for use in promoting or enhancing the state of wakefulness, alertness, and/or central nervous system stimulation in an individual.
    Type: Application
    Filed: July 21, 2006
    Publication date: May 14, 2009
    Inventors: Eyal S. Ron, Neal M. Farber, Daniel E. Katzman, Elkan R. Gamzu
  • Patent number: 6491643
    Abstract: A breath test analyzer, which analyzes exhaled breaths of a patient for isotope labeled products generated in the patient's body after ingestion by the patient of an isotope labeled substance, where the presence of these isotope labeled products provide an indication of a medical condition in the patient. The analyzer uses a very sensitive infra-red spectrophotometer, which enables it to continuously collect and analyze multiple samples of the patient's breath, and process the outputs in real time, while the patient is still connected to the analyzer, such that a definitive result is obtained within a short time, such as the order of a few minutes. The breath test analyzer is sufficiently small that it can be easily accomodated in the office of a physician. The breath test analyzer can be utilized for a number of diagnostic breath tests, according to the isotope labeled substance ingested by the patient and the gases detected in the patient's breath.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: December 10, 2002
    Assignee: Oridion Medical Ltd.
    Inventors: Daniel E. Katzman, Ephraim Carlebach
  • Publication number: 20010021815
    Abstract: A breath test analyzer, which analyzes exhaled breaths of a patient for isotope labeled products generated in the patient's body after ingestion by the patient of an isotope labeled substance, where the presence of these isotope labeled products provide an indication of a medical condition in the patient. The analyzer uses a very sensitive infra-red spectrophotometer, which enables it to continuously collect and analyze multiple samples of the patient's breath, and process the outputs in real time, while the patient is still connected to the analyzer, such that a definitive result is obtained within a short time, such as the order of a few minutes. The breath test analyzer is sufficiently small that it can be easily accomodated in the office of a physician. The breath test analyzer can be utilized for a number of diagnostic breath tests, according to the isotope labeled substance ingested by the patient and the gases detected in the patient's breath.
    Type: Application
    Filed: January 22, 2001
    Publication date: September 13, 2001
    Inventors: Daniel E. Katzman, Ephraim Carlebach
  • Patent number: 6186958
    Abstract: A breath test analyzer, which analyzes exhaled breaths of a patient for isotope labeled products generated in the patient's body after ingestion by the patient of an isotope labeled substance, where the presence of these isotope labeled products provide an indication of a medical condition in the patient. The analyzer uses a very sensitive infra-red spectrophotometer, which enables it to continuously collect and analyze multiple samples of the patient's breath, and process the outputs in real time, while the patient is still connected to the analyzer, such that a definitive result is obtained within a short time, such as the order of a few minutes. The breath test analyzer is sufficiently small that it can be easily accomodated in the office of a physician. The breath test analyzer can be utilized for a number of diagnostic breath tests, according to the isotope labeled substance ingested by the patient and the gases detected in the patient's breath.
    Type: Grant
    Filed: September 10, 1998
    Date of Patent: February 13, 2001
    Assignee: Oridion Medical
    Inventors: Daniel E. Katzman, Ephraim Carlebach
  • Patent number: 6180414
    Abstract: A breath test for determining the rate of metabolism of a drug is described. First, a safe and effective amount of the drug, preferably appropriately labelled and most preferably isotopically-labelled, is administered to a subject. After a suitable time period, the exhaled breath of the subject is analyzed to determine the concentration of a metabolite. The concentration of the metabolite is then used to determine the rate of metabolism of the drug. A breath test kit is also described. Such a breath test kit would include an item or items necessary for performing at least one of the methods of determining the rate of metabolism of a drug in a subject. For example, such a breath test kit could include an isotopically-labelled drug to be administered to the subject.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: January 30, 2001
    Assignee: Oridion Medical Ltd.
    Inventor: Daniel E. Katzman
  • Patent number: 6067989
    Abstract: A breath test for diagnosing the presence of Helicobacter pylori in a subject is described. The method of diagnosing Helicobacter pylori is performed as follows. First, a safe and effective amount of urea, preferably appropriately labelled, is administered to the subject. Second, a plurality of the exhaled breaths of the subject is analyzed to detect the concentration of a cleavage product or products, produced when urease cleaves the substrate. The measured concentrations are then fitted to a curve, and the derivative is then calculated, to indicate the presence or absence of Helicobacter pylori infection in the subject.
    Type: Grant
    Filed: February 26, 1997
    Date of Patent: May 30, 2000
    Assignee: Oridion Medical, Ltd.
    Inventor: Daniel E. Katzman
  • Patent number: 5962335
    Abstract: A breath test for determining the rate of metabolism of a drug is described. First, a safe and effective amount of the drug, preferably appropriately labelled and most preferably isotopically-labelled, is administered to a subject. After a suitable time period, the exhaled breath of the subject is analyzed to determine the concentration of a metabolite. The concentration of the metabolite is then used to determine the rate of metabolism of the drug. A breath test kit is also described. Such a breath test kit would include an item or items necessary for performing at least one of the methods of determining the rate of metabolism of a drug in a subject. For example, such a breath test kit could include an isotopically-labelled drug to be administered to the subject.
    Type: Grant
    Filed: January 3, 1997
    Date of Patent: October 5, 1999
    Assignee: Oridion Medical Ltd.
    Inventor: Daniel E. Katzman
  • Patent number: 5944670
    Abstract: A breath test for diagnosing the presence of Chlamydia species, such as Chlamydia pneumoniae, in a subject is described. The method of diagnosing Chlamydia species in a subject is performed as follows. First, a safe and effective amount of a substrate, preferably appropriately labelled, is administered to the subject. Second, the exhaled breath of the subject is analyzed to detect the concentration of a cleavage product or products, produced when an enzyme from Chlamydia bacteria cleaves the substrate. The presence of the cleavage product or products indicates a positive diagnosis of Chlamydia species in the subject. A breath test kit is also described. Such a breath test kit would include an item or items necessary for performing at least one of the methods of diagnosing Chlamydia species in a subject. For example, such a breath test kit could include a substrate to be administered to the subject.
    Type: Grant
    Filed: December 2, 1996
    Date of Patent: August 31, 1999
    Assignee: Oridion Medical Ltd.
    Inventor: Daniel E. Katzman
  • Patent number: RE38728
    Abstract: A breath test analyzer, which analyzes exhaled breadths of a patient for isotope labeled products generated in the patient's body after ingestion by the patient of an isotope labeled substance, where the presence of these isotope labeled products provide an indication of a medical condition in the patient. The analyzer uses a very sensitive infra-red spectrophotometer, which enables it to continuously collect and analyze multiple samples of the patient's breath, and process the outputs in real time, while the patient is still connected to the analyzer, such that a definitive result is obtained within a short time, such as the order of a few minutes. The breath test analyzer is sufficiently small in that it can be easily accommodated in the office of a physician. The breath test analyzer can be utilized for a number of diagnostic breath tests, according to the isotope labeled substance ingested by the patient and the gases detected in the patient's breath.
    Type: Grant
    Filed: April 16, 2002
    Date of Patent: April 19, 2005
    Assignee: Oridion Medical, LTD
    Inventors: Daniel E. Katzman, Ephraim Carlebach